Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Goa Carbon: Elevated green coke prices key to watch out for

21h moneycontrol
Goa Carbon, the second largest manufacturer of calcined petroleum coke (CPC) in India, provided a weak start to the earnings calendar for carbon companies. Sequential growth numbers weakened despite improved product realisations due to lower sales, amid plant shutdowns and lower shipments. While strong end market demand and order backlog keep us positive on sales improvement, the surge in raw material cost needs to be watched closely.
RAIN GOACARBON 500339 509567

0
Rain Carbon to build water-white resins plant in Germany

2018-07-03 thehindubusinessline
Rain Carbon Inc, a step-down wholly-owned subsidiary of Rain Industries, on Tuesday said that it will begin construction of a new resin polymerisation and hydrogenation plant in mid-July at its integrated coal tar and petrochemicals site in Castrop-Rauxel, Germany.
RAIN 500339

0
Rain Industries Limited - Press Release

2018-07-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
RAIN 500339

0
Rain Industries Limited - Press Release

2018-06-22 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
RAIN 500339

0
Sebi initiates probe into alleged leak of list of cos under enhanced surveillance measures

2018-06-06 moneycontrol
Markets regulator Sebi today said it has initiated a probe into alleged leak of 37 companies being brought under enhanced surveillance before stock exchanges made the list public.
RAIN 532497 500339 RADICO

0
List of stocks on SEBI’s ‘monitor list’ was leaked, suspect traders

2018-06-05 thehindubusinessline
Was a list of stocks that were to be included in Additional Surveillance Measure (ASM), the new category formed by SEBI to check market manipulation, leaked to operators ahead of its official release? A section of stock market brokers and top traders suspect that operators in Mumbai and Gujarat may have had access to the list on May 31 before it was officially put up on stock exchange websites.
517421 ALNSE 500339 513269 MANINDS 533333 RAIN 532497 FCL RADICO BUTTERFLY EXCELINDUS 500650

5
BSE brings 109 firms under enhanced surveillance

2018-06-04 moneycontrol
Leading stock exchange BSE today decided to bring 109 companies, including Reliance Naval and Engineering, Amtek Auto, GVK Power & Infrastructure under enhanced surveillance measures. "...100 percent margins shall be applicable with effect from June 6, 2018 on all open positions as on June 5, 2018 and new positions created from June 6, 2018 onwards," the exchange said in a circular.
532960 AMKD RAIN 533207 JPINFRATEC IBVENTURES 500339 AMTEKAUTO 520077 IDBLZ 532775 GTLINFRA

0
Rain Industries Limited - Analysts/Institutional Investor Meet/Con. Call Updates

2018-05-16 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
RAIN 500339

0
Rain Industries Limited - Shareholders meeting

2018-05-12 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
RAIN 500339

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to NSE:RAIN / Rain Industries Limited on message board site Silicon Investor.

Human Brain, The Brain Teasers.
Blue Eyes Crying in the Rain Braintech Inc. BRHI Robotics
Halltrain Entertainment Inc. HTRN CANADIAN OTC. Bombardier, maker of planes and trains and other things
Grain Futures Trading BCLI - BrainStorm Cell Therapeutics Inc.
UFSI - Ukraine Financial Services, Inc. CrAzY fOoLs ChAsInG rAiNbOwS